Edwards Lifesciences EW Cash Flow Statement (2009-2026)

NYSE EW
$88.09 +0.87 (+1.00%)
As of: Oct 20, 2026 · 11:24 AM EDT
Reported Financials

Edwards Lifesciences Quarterly Cash Flow Statement

Periods 69 quarters
Latest Jun 2026

Edwards Lifesciences reported cash from operations of $651.90M and free cash flow of $585.00M for the quarter ended Jun 2026, up 124.6% year over year. This cash flow statement covers 69 quarters of results from Jun 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
340.10M335.30M373.60M406.40M343.50M398.40M340.50M307.10M384.90M369.90M351.00M365.00M3,070.80M385.60M356.40M333.20M291.10M91.20M380.70M241.90M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
33.60M33.00M34.70M34.10M35.40M35.40M35.20M36.10M36.90M36.70M38.50M39.60M34.50M42.60M36.60M38.10M39.20M42.70M40.90M42.70M
Share-based CompensationStock Comp.
26.60M24.20M32.40M36.20M30.30M27.90M38.90M37.40M32.60M30.50M44.60M43.90M42.10M31.70M40.20M37.50M41.20M39.20M45.40M42.20M
Deferred Taxes
3.90M-61.50M-42.60M-59.80M-46.30M-105.80M-51.80M-82.90M-46.00M-91.40M-35.80M-66.10M-123.00M-98.50M-24.30M-20.90M-18.00M-54.40M9.40M181.30M
Gains from Sales and DivestituresGains Divest
10.80M33.90M
Gains from Investment SecuritiesGains Investment
8.70M11.20M-10.90M-2.40M-3.50M1.00M24.60M-12.50M12.50M65.20M19.90M
Asset Writedowns and ImpairmentWritedown
47.10M40.00M146.90M123.60M40.00M
Other non-cash itemsOther Non-Cash
1.10M-6.90M24.60M-20.90M-12.50M9.40M7.90M-26.90M7.20M8.20M16.70M9.70M11.10M-12.50M12.00M7.00M-4.20M
Change in Working Capital
Change in ReceivablesChange Receivables
-38.00M-6.80M57.80M19.90M5.30M1.10M77.50M46.80M-1.30M18.20M55.00M-23.00M-47.30M-105.90M43.70M24.90M-13.20M-32.40M117.90M10.20M
Change in InventoryChange Inventory
-8.10M6.60M24.00M61.80M65.30M62.30M32.80M80.90M76.00M99.30M69.50M94.20M41.20M51.20M0.10M-41.60M1.80M-11.00M1.60M23.50M
Change in Accured ExpensesChange Accured Exp.
79.30M31.10M-109.20M27.50M26.00M34.30M-45.20M121.40M36.40M33.40M-89.10M151.80M29.90M-3.10M-103.40M103.70M226.10M168.70M-347.10M123.70M
Change in TaxesChange Taxes
5.80M33.00M82.90M-33.20M-40.90M-14.40M87.20M-56.20M75.30M-112.10M-263.10M-106.90M671.80M-488.50M51.20M-240.40M-10.20M57.60M41.90M12.00M
Change in Other Operating AssetsOther Assets Change
-1.10M-6.40M-1.70M-24.00M5.40M20.20M23.80M133.60M18.20M16.10M-27.10M-13.00M12.70M-3.60M-10.60M13.90M14.20M-2.10M8.70M-29.50M
Change in Other Operating LiabilitiesOther Liabilities Change
-22.80M-10.10M-10.00M-9.70M-16.40M-8.90M29.30M-43.80M-11.50M-7.00M-5.20M-6.60M-12.50M-12.50M-36.70M-12.50M-12.50M-14.80M-50.00M
Other Working Capital ChangesOther WC Changes
13.10M0.10M-13.00M-19.50M-7.20M-12.30M6.20M-1.50M-19.50M3.20M-4.20M-0.90M1.00M-17.30M-28.60M4.70M-7.90M-2.70M-18.10M0.40M
Cash from OperationsCash from Ops.
531.90M373.60M293.30M332.20M309.90M282.80M314.10M33.60M411.50M136.60M-53.50M371.50M351.80M-127.50M280.40M290.20M573.70M450.90M43.80M651.90M
Investing Activities
Capital ExpendituresCapex
60.70M89.80M72.70M43.10M59.90M68.90M61.50M47.90M55.30M88.30M65.30M85.40M51.90M49.80M56.00M49.30M57.50M97.40M64.90M66.90M
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in Property, Plant and EquipmentChange in PP&E
-60.70M-89.80M-72.70M-43.10M-59.90M-68.90M-61.50M-47.90M-55.30M-88.30M-65.30M-85.40M-51.90M-49.80M-56.00M-49.30M-57.50M-97.40M-64.90M-66.90M
Change in IntangiblesChange Intangibless
13.10M0.20M20.00M5.40M4.60M
Acquisitions
7.40M55.50M52.10M2.00M15.00M30.80M10.80M6.00M32.30M57.40M3.00M62.30M4.10M20.50M6.30M7.10M
Divestments
-3,927.40M
Net of Acquisitions & DivestmentsNet Acquisitions
-7.40M-55.50M-52.10M-2.00M-15.00M-30.80M-10.80M-6.00M-32.30M-3,984.80M-3.00M-62.30M-4.10M-20.50M-6.30M-7.10M
Purchase of InvestmentsInvestments Purchased
413.50M1,054.30M202.10M92.90M293.30M81.00M15.70M6.60M9.60M43.60M2.60M13.30M539.20M390.70M647.30M630.30M1,030.80M826.70M653.60M564.10M
Sale and Maturity of InvestmentsInvestments Sold
113.60M197.10M502.00M359.60M224.00M273.50M263.90M134.10M180.40M137.40M166.60M247.00M175.90M268.10M845.60M626.10M691.90M714.50M722.60M448.50M
Other Investing ActivitiesOther investing
-16.80M-7.50M2.30M-38.50M-20.20M-6.70M-16.90M-9.20M-26.50M-6.60M-4.80M-17.50M-9.20M-44.10M-17.70M-56.30M-27.30M-47.00M-55.50M-5.00M
Cash from Investing ActivitiesCash from Investing
-377.40M-965.90M229.50M129.60M-201.50M94.70M0.50M70.20M89.00M14.10M63.10M124.80M2,701.70M-576.70M85.30M-172.10M-427.80M-198.30M-92.80M-193.20M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
-8.80M
Long-Term Debt RepaymentsLT Debt Repayment
-8.70M0.10M0.10M0.10M
Non-Current Debt
-0.10M-0.10M-0.10M-0.10M
Short-Term Debt issuancesST Debt Issuance
Short-Term Debt repaymentsST Debt Repayment
Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.10M-0.10M-0.10M-0.10M
Change in Capital Stock
Common Stock IssuedStock Issued
38.90M33.90M37.50M49.00M32.40M27.50M41.90M60.80M34.00M33.20M62.10M54.30M34.50M28.60M49.90M57.20M34.70M32.30M68.90M53.80M
Shares Repurchased
1.80M96.50M405.60M355.10M100.40M866.00M249.30M7.50M174.40M448.40M0.20M158.10M901.00M100.10M258.60M5.50M588.70M40.60M421.80M153.30M
Net Shares Issued and RepurchasedNet Shares Issued
37.10M-62.60M-368.10M-306.10M-68.00M-838.50M-207.40M53.30M-140.40M-415.20M61.90M-103.80M-866.50M-71.50M-208.70M51.70M-554.00M-8.30M-352.90M-99.50M
Net Equity Issued and RepurchasedNet Equity Issued
37.10M-62.60M-368.10M-306.10M-68.00M-838.50M-207.40M53.30M-140.40M-415.20M61.90M-103.80M-866.50M-71.50M-208.70M51.70M-554.00M-8.30M-352.90M-99.50M
Other financing activitiesOther financing
2.00M0.70M-2.00M-1.90M0.10M0.80M-1.20M-2.90M2.00M-0.20M7.20M-10.20M0.10M0.70M1.00M-236.10M-3.10M1.70M-0.80M
Cash from Financing ActivitiesCash from Financing
39.00M-62.00M-368.10M-308.10M-69.90M-838.40M-206.60M52.10M-143.30M-413.20M61.70M-96.60M-976.70M28.60M-258.00M52.70M-740.10M-11.40M-451.20M-0.30M
Additional items
Exchange Rate EffectFX Effect
0.50M1.80M13.20M13.90M10.30M-18.20M-4.20M15.20M9.20M-3.40M9.70M29.40M-51.50M51.00M-17.70M-29.60M-1.00M3.50M8.20M3.80M
Change in Cash
194.00M-652.50M167.90M167.60M48.80M-479.10M103.80M171.10M366.40M-265.90M81.00M429.10M2,025.30M-624.60M90.00M141.20M-595.20M244.70M-492.00M462.20M
Ending Cash Balance
1,519.90M867.40M1,035.30M1,202.90M1,251.70M772.60M876.40M1,047.50M1,413.90M1,148.00M1,229.00M1,658.10M3,683.40M3,058.80M3,148.80M3,290.00M2,694.80M2,939.50M2,447.50M2,909.70M
Free Cash FlowFCF
471.20M283.80M220.60M289.10M250.00M213.90M252.60M-14.30M356.20M48.30M-118.80M286.10M299.90M-177.30M224.40M240.90M516.20M353.50M-21.10M585.00M
Net Cash FlowNCF
193.50M-654.30M154.70M153.70M38.50M-460.90M108.00M155.90M357.20M-262.50M71.30M399.70M2,076.80M-675.60M107.70M170.80M-594.20M241.20M-500.20M458.40M
Income Taxes PaidTaxes Paid

Edwards Lifesciences Cash Flow Statement API

Pull Edwards Lifesciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=EW&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY